Reuters logo
BRIEF-InDex Pharmaceuticals Holding Q1 operating loss widens to SEK 22.1 mln
May 30, 2017 / 6:20 AM / 6 months ago

BRIEF-InDex Pharmaceuticals Holding Q1 operating loss widens to SEK 22.1 mln

May 30 (Reuters) - INDEX PHARMACEUTICALS HOLDING AB :

* Q1 OPERATING LOSS SEK 22.1 MILLION VERSUS LOSS SEK 6.9 MILLION YEAR AGO

* Q1 RESULT AFTER TAX LOSS SEK 22.0 MILLION VERSUS LOSS 7.1 MILLION YEAR AGO

* FOCUS REMAINS ON IMPLEMENTATION OF PHASE IIB STUDY CONDUCT WITH LEAD DRUG CANDIDATE COBITOLIMOD Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below